Orchestra BioMed Receives $6.1M Milestone From Vivasure Deal
Orchestra BioMed received $6.1M on Sept. 14, 2026 as the first milestone from Haemonetics’ acquisition of Vivasure, bringing 2026 proceeds to about $11M. The company may receive up to about $10M more via future revenue earnouts, subject to milestones.Material DetailsContext by AI AnalystThis is a m…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.